Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(S)-(-)-MRJF22, a haloperidol metabolite II valproate ester, demonstrates potent antimigratory effects in both endothelial and tumor cells, and is considered a promising multifunctional agent in the treatment of uveal melanoma [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | (S)-(-)-MRJF22, a haloperidol metabolite II valproate ester, demonstrates potent antimigratory effects in both endothelial and tumor cells, and is considered a promising multifunctional agent in the treatment of uveal melanoma [1]. |
Molecular Weight | 504.08 |
Formula | C29H39ClFNO3 |
CAS No. | 2757301-90-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(S)-(-)-MRJF22 2757301-90-7 inhibitor inhibit